Clinical Trials Browser

Phase 3 × Terminated × Neuroprotective Agents × Clear all

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Phase 3 Terminated

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms